ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

1.42
0.03
(2.16%)
마감 01 2월 6:00AM
1.42
0.00
(0.00%)
시간외 거래: 9:49AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
1.42
매수가
0.92
매도가
2.41
거래량
605,841
1.37 일간 변동폭 1.475
0.63 52주 범위 2.50
market_cap
전일 종가
1.39
개장가
1.38
최근 거래 시간
705
@
1.42
(formt)
마지막 거래 시간
재정 규모
US$ 859,786
VWAP
1.4192
평균 볼륨(3m)
768,072
발행 주식
68,673,612
배당수익률
-
주가수익률
-0.82
주당순이익(EPS)
-1.72
매출
-
순이익
-117.86M

Vor Biopharma Inc 정보

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker VOR. The last closing price for Vor Biopharma was US$1.39. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.63 to US$ 2.50.

Vor Biopharma currently has 68,673,612 shares in issue. The market capitalisation of Vor Biopharma is US$95.46 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.82.

VOR 최신 뉴스

Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors

CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of...

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.17-10.69182389941.591.591.32254305871.40314951CS
40.2420.33898305081.181.81.178150681.50130049CS
120.586970.44772536310.83311.80.72027680721.19013293CS
260.4952.6881720430.931.80.638274800.99683398CS
52-1.03-42.04081632652.452.50.635699141.18601977CS
156-6.425-81.89929891657.8459.720.632817052.31309944CS
260-40.6-96.620656830142.0263.620.632511606.02088408CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?
The current share price of Vor Biopharma is US$ 1.42
How many Vor Biopharma shares are in issue?
Vor Biopharma has 68,673,612 shares in issue
What is the market cap of Vor Biopharma?
The market capitalisation of Vor Biopharma is USD 95.46M
What is the 1 year trading range for Vor Biopharma share price?
Vor Biopharma has traded in the range of US$ 0.63 to US$ 2.50 during the past year
What is the PE ratio of Vor Biopharma?
The price to earnings ratio of Vor Biopharma is -0.82
What is the reporting currency for Vor Biopharma?
Vor Biopharma reports financial results in USD
What is the latest annual profit for Vor Biopharma?
The latest annual profit of Vor Biopharma is USD -117.86M
What is the registered address of Vor Biopharma?
The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vor Biopharma website address?
The website address for Vor Biopharma is www.vorbio.com
Which industry sector does Vor Biopharma operate in?
Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.87M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.57M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.8M

VOR Discussion

게시물 보기
PonkenPlonken PonkenPlonken 1 주 전
theres this board Biotech Values - they will one up each other on how much the 16th drug in Pfizers portfolio will generate in sales 2025 but never look at anything like this?
👍️0
PonkenPlonken PonkenPlonken 4 주 전
zipline all day
👍️0
PonkenPlonken PonkenPlonken 4 주 전
not letting up
👍️0
Monksdream Monksdream 1 월 전
VOR, ten day hourly
👍️ 1
Monksdream Monksdream 1 월 전
So it’s a CRSPR stock
Certainly when Jennifer Doudna and Emanelle Charpentier who won the 2020 chemistry Nobel wanted to share their discovery
Gene editing in many respects remains in the R&D stage
They require tons of money to continue research
👍️0
PonkenPlonken PonkenPlonken 1 월 전
In good company:
"Under the deal, Vor Bio will issue 55.9 million common stock shares and corresponding warrants to buy an additional 69.8 million shares at a combined price of $0.99425 per share and warrant. The warrants, exercisable at $0.838 per share, might be used until 2031, hence perhaps adding $58.5 million in profits if completely used.

New investor Reid Hoffman spearheaded the fundraising with major shareholder RA Capital Management, Vor Bio. As agreed upon, each will get board representation. Hoffman called the company's trem-cel therapy which targets acute myeloid leukemia using CRISpen/Cas9 technology a hopeful development in cancer treatment."

https://en.wikipedia.org/wiki/Reid_Hoffman

https://finance.yahoo.com/news/vor-biopharma-secures-55-6m-142740239.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAG0tuNK9MvQB11zJKjsCQuEXY65q6qJMzVa2xMmGe_UPW73P3TlZrz53TlAto0KIOzFJ1VOTQl_6hH3osmqgEEGKEQk_aQUDk2rx8achcDajSgaiFx67nHkqOXSvZcVp8ESdlQrR50KKetBIcDD94B2WvRxwy_U_Dyng_1W8jD1d
👍️0
PonkenPlonken PonkenPlonken 1 월 전
close above 200??
👍️0
PonkenPlonken PonkenPlonken 1 월 전
Money goes where its treated best.... now imagine what the stock can do on actual data
👍️0
PonkenPlonken PonkenPlonken 1 월 전
not bad
still looking for a VINC move! waiting for the unveil
👍️0
PonkenPlonken PonkenPlonken 1 월 전
GOOD stuff - remember traded at .8s last weeks

Vor Bio will issue an aggregate of 55,871,260 shares of common stock and accompanying warrants to purchase an aggregate of 69,839,075 shares of common stock at a combined price of $0.99425 per share and accompanying warrants. The warrants will have a per share exercise price of $0.838 and may be exercised at any time on or after the closing date and through the seventh anniversary of the closing date
https://www.globenewswire.com/news-release/2024/12/27/3002259/0/en/Vor-Bio-Announces-55-6-Million-Private-Placement.html
👍️0
PonkenPlonken PonkenPlonken 1 월 전
beam me up scotty
👍️0
PonkenPlonken PonkenPlonken 2 월 전
readying here
👍️0
PonkenPlonken PonkenPlonken 3 월 전
VINC type move coming
👍️0
PonkenPlonken PonkenPlonken 3 월 전
super super undervalued. Sid Mukherjee - gifted founder. Couple with recent clinical validation...
Problem in AML is not the drugs efficacy rather the possibility to handle the drug. They might just fix that.
👍️0
PonkenPlonken PonkenPlonken 3 월 전
good dip buy
👍️0
PonkenPlonken PonkenPlonken 5 월 전
The buyers of all these shares arent going anywhere. Waiting for it to unfold.
All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal
👍️0
PonkenPlonken PonkenPlonken 5 월 전
remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.
👍️0
PonkenPlonken PonkenPlonken 5 월 전
Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.
👍️0
glenn1919 glenn1919 5 월 전
VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 월 전
VOR new 52 week low
👍️0
Monksdream Monksdream 7 월 전
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 7 월 전
Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
👍️0
Monksdream Monksdream 7 월 전
GNPX new 52 week low

👍️0
PonkenPlonken PonkenPlonken 7 월 전
Im starting to think someone just buys them out.
Interesting action yesterday.
👍️0
Monksdream Monksdream 8 월 전
VOR new 52 week low
👍️0
Monksdream Monksdream 8 월 전
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 8 월 전
elevated volume for quite some time now.
👍️0
PonkenPlonken PonkenPlonken 9 월 전
https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
👍️0
Monksdream Monksdream 10 월 전
VORBunder $2
👍️0
glenn1919 glenn1919 11 월 전
VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0

최근 히스토리

Delayed Upgrade Clock